{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:42:12Z","timestamp":1784864532943,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":39,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jbc.2021.100403","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:17:22Z","timestamp":1613607442000},"page":"100403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Targeting primary and metastatic uveal melanoma with a G\u00a0protein inhibitor"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4082-1105","authenticated-orcid":false,"given":"Michael D.","family":"Onken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol M.","family":"Makepeace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Kaltenbronn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonel","family":"Hernandez-Aya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine N.","family":"Weilbaecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kisha D.","family":"Piggott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Kumar","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla M.","family":"Yuede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alethia J.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4581-7044","authenticated-orcid":false,"given":"Patrick","family":"Osei-Owusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5743-6206","authenticated-orcid":false,"given":"Kendall J.","family":"Blumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2021.100403_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.100403_bib2","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2021.100403_bib3","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1167\/iovs.08-2145","article-title":"Oncogenic mutations in GNAQ occur early in uveal melanoma","volume":"49","author":"Onken","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jbc.2021.100403_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-009-0611-3","article-title":"Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system","volume":"119","author":"K\u00fcsters-Vandevelde","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2021.100403_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejca.2016.06.019","article-title":"GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis","volume":"65","author":"Sheng","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbc.2021.100403_bib6","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/PAS.0000000000001110","article-title":"Frequent GNAQ and GNA14 mutations in hepatic small vessel neoplasm","volume":"42","author":"Joseph","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jbc.2021.100403_bib7","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","article-title":"Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ","volume":"368","author":"Shirley","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2021.100403_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jamaophthalmol.2018.5141","article-title":"Association of somatic GNAQ mutation with Capillary Malformations in a case of choroidal hemangioma","volume":"137","author":"Bichsel","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.jbc.2021.100403_bib9","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit \u03b111 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2021.100403_bib10","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2014-1029","article-title":"Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: Phenotypic and molecular characterization","volume":"99","author":"Li","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2021.100403_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ophtha.2018.12.011","article-title":"GNAQ mutations in Diffuse and Solitary choroidal hemangiomas","volume":"126","author":"Francis","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jbc.2021.100403_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/OPTH.S89591","article-title":"Uveal melanoma: epidemiology, etiology, and treatment of primary disease","volume":"11","author":"Krantz","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jbc.2021.100403_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bjophthalmol-2016-309034","article-title":"Metastatic disease from uveal melanoma: treatment options and future prospects","volume":"101","author":"Carvajal","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jbc.2021.100403_bib14","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1074\/jbc.REV119.007061","article-title":"Heterotrimeric Gq proteins as therapeutic targets?","volume":"295","author":"Kostenis","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100403_bib15","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1021\/jo00247a030","article-title":"Structure of FR900359, a cyclic depsipeptide from Ardisia crenata Sims","volume":"53","author":"Fujioka","year":"1988","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.jbc.2021.100403_bib16","doi-asserted-by":"crossref","first-page":"10156","DOI":"10.1038\/ncomms10156","article-title":"The experimental power of FR900359 to study Gq-regulated biological processes","volume":"6","author":"Schrage","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2021.100403_bib17","doi-asserted-by":"crossref","first-page":"eaao6852","DOI":"10.1126\/scisignal.aao6852","article-title":"Targeting nucleotide exchange to inhibit constitutively active G protein a subunits in cancer cells","volume":"11","author":"Onken","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2021.100403_bib18","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/1541-7786.MCR-18-0574","article-title":"Effects of oncogenic G\u03b1q and G\u03b111 inhibition by FR900359 in uveal melanoma","volume":"17","author":"Lapadula","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2021.100403_bib19","doi-asserted-by":"crossref","first-page":"eaau5948","DOI":"10.1126\/scisignal.aau5948","article-title":"Direct targeting of G\u03b1 q and G\u03b1 11 oncoproteins in cancer cells","volume":"12","author":"Annala","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2021.100403_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ccell.2019.01.009","article-title":"A\u00a0platform of Synthetic lethal gene interaction networks reveals that the GNAQ uveal melanoma oncogene controls the Hippo pathway through FAK","volume":"35","author":"Feng","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2021.100403_bib21","doi-asserted-by":"crossref","first-page":"47438","DOI":"10.1074\/jbc.M408846200","article-title":"A\u00a0novel Galphaq\/11-selective inhibitor","volume":"279","author":"Takasaki","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100403_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1160\/TH04-09-0635","article-title":"Pharmacological properties of YM-254890, a specific G\u03b1 q\/11 inhibitor, on thrombosis and neointima formation in mice","volume":"94","author":"Kawasaki","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jbc.2021.100403_bib23","doi-asserted-by":"crossref","first-page":"eaag2288","DOI":"10.1126\/scitranslmed.aag2288","article-title":"Targeted inhibition of Gq signaling induces airway relaxation in mouse models of asthma","volume":"9","author":"Matthey","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2021.100403_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.phrs.2019.01.012","article-title":"Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for G q\/11 class G proteins","volume":"141","author":"Meleka","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jbc.2021.100403_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/cvr\/cvv216","article-title":"Endothelial G\u03b1 q\/11 is required for VEGF-induced vascular permeability and angiogenesis","volume":"108","author":"Sivaraj","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jbc.2021.100403_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ydbio.2005.03.006","article-title":"Characteristic defects in neural crest cell-specific G\u03b1q\/G\u03b111- and G\u03b112\/G\u03b113-deficient mice","volume":"282","author":"Dettlaff-Swiercz","year":"2005","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jbc.2021.100403_bib27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/syn.21830","article-title":"Deletion of G\u03b1q in the telencephalon alters specific neurobehavioral outcomes","volume":"69","author":"Graham","year":"2015","journal-title":"Synapse"},{"key":"10.1016\/j.jbc.2021.100403_bib28","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm1101-1236","article-title":"Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of G\u03b1q\/G\u03b111 in cardiomyocytes","volume":"7","author":"Wettschureck","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2021.100403_bib29","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1093\/emboj\/17.15.4304","article-title":"Embryonic cardiomyocyte hypoplasia and craniofacial defects in G\u03b1(q)\/G\u03b111-mutant mice","volume":"17","author":"Offermanns","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2021.100403_bib30","article-title":"Combined inhibition of G\u03b1q and MEK Enhances therapeutic efficacy in uveal melanoma","author":"Hitchman","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2021.100403_bib31","doi-asserted-by":"crossref","first-page":"e0178189","DOI":"10.1371\/journal.pone.0178189","article-title":"Systematic genomic and translational efficiency studies of uveal melanoma","volume":"12","author":"Johnson","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2021.100403_bib32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical Subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2021.100403_bib33","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","article-title":"Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death","volume":"64","author":"Onken","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2021.100403_bib34","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","article-title":"Collaborative ocular oncology group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma","volume":"119","author":"Onken","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jbc.2021.100403_bib35","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science (80-. )"},{"key":"10.1016\/j.jbc.2021.100403_bib36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1755-148X.2012.00971.x","article-title":"Genetic and molecular characterization of uveal melanoma cell lines","volume":"25","author":"Griewank","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.jbc.2021.100403_bib37","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.molonc.2014.06.004","article-title":"Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target","volume":"8","author":"Amirouchene-Angelozzi","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jbc.2021.100403_bib38","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0002-9440(10)64817-1","article-title":"Deregulation of the Rb and p53 pathways in uveal melanoma","volume":"157","author":"Brantley","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jbc.2021.100403_bib39","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1160\/TH03-02-0115","article-title":"Antithrombotic and thrombolytic efficacy of YM-254890, a Gq\/II inhibitor, in a rat model of arterial thrombosis","volume":"90","author":"Kawasaki","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jbc.2021.100403_bib40","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1152\/physrev.00003.2005","article-title":"Mammalian G proteins and their cell type specific functions","volume":"85","author":"Wettschureck","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jbc.2021.100403_bib41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccell.2017.04.002","article-title":"RasGRP3 Mediates MAPK pathway activation in GNAQ mutant uveal melanoma","volume":"31","author":"Chen","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2021.100403_bib42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1158\/1541-7786.MCR-17-0007","article-title":"Dysregulated GPCR signaling and therapeutic options in uveal melanoma","volume":"15","author":"Chua","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2021.100403_bib43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00008390-199912000-00006","article-title":"Uveal melanoma: Natural history and treatment options for metastatic disease","volume":"9","author":"W\u00f6ll","year":"1999","journal-title":"Melanoma Res."},{"key":"10.1016\/j.jbc.2021.100403_bib44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1148\/radiol.2019190199","article-title":"A\u00a0prospective Phase II trial of radioembolization for treatment of uveal melanoma hepatic metastasis","volume":"293","author":"Gonsalves","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.jbc.2021.100403_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0033-1333652","article-title":"Transhepatic therapies for metastatic uveal melanoma","volume":"30","author":"Eschelman","year":"2013","journal-title":"Semin. Intervent. Radiol."},{"key":"10.1016\/j.jbc.2021.100403_bib46","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.ophtha.2005.06.011","article-title":"Estimating the risk of malignant transformation of a choroidal nevus","volume":"112","author":"Singh","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jbc.2021.100403_bib47","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1158\/1535-7163.MCT-06-0782","article-title":"CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling","volume":"6","author":"Evelyn","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2021.100403_bib48","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/onc.2010.442","article-title":"P38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis","volume":"30","author":"Delston","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2021.100403_bib49","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/1471-2407-13-371","article-title":"BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma","volume":"13","author":"Matatall","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbc.2021.100403_bib50","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.100403_bib51","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.kint.2017.04.044","article-title":"Elastin insufficiency causes hypertension, structural defects and abnormal remodeling of renal vascular signaling","volume":"92","author":"Owens","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.jbc.2021.100403_bib52","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.nbd.2004.08.006","article-title":"Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning\/memory deficits in juveniles followed by progressive functional recovery in adults","volume":"17","author":"Wozniak","year":"2004","journal-title":"Neurobiol. Dis."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821001757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821001757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T04:03:19Z","timestamp":1634443399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925821001757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":52,"alternative-id":["S0021925821001757"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100403","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting primary and metastatic uveal melanoma with a G\u00a0protein inhibitor","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100403"}}